One of those GPCRs is GPR30/GPER, which has been found to exert positive impacts on female HF patients [34], via its engagement in non-genomic estrogen signal transduction in nervous, reproductive, skeletal, immune, and cardiovascular systems, as well as in metabolism [35]. Here, GPER1 is linked to hydrops fetalis.